Publications by authors named "D Borchiellini"

Claim this Profile
C
Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinion.
Delphine Borchiellini, Gwenaelle Gravis, Emmanuel Gross, Jean-Michel Hannoun-Levi, Jean-François Berdah

Fr J Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A 2025 inventory in oncology news].
Stéphane Vignot, Audrey Bellesoeur, Delphine Borchiellini, Carole Bouleuc, Romain Cohen

Bull Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study.
Ronan Flippot, Yann-Alexandre Vano, Cécile Dalban, Benoit Beuselinck, Aude Fléchon, Delphine Borchiellini

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial.
Brian I Rini, Elizabeth R Plimack, Viktor Stus, Rustem Gafanov, Tom Waddell, Delphine Borchiellini

Nat Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Talazoparib in combination with enzalutamide in metastatic castration-resistant prostate cancer].
Mathilde Gout, Delphine Borchiellini

Bull Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis